University of Cambridge portfolio firms raise more than £30m in 10 months

Cambridge Enterprise Ltd said it has seen more than £30m invested in 13 of its portfolio companies since September last year.

In May £5.1m was invested into Metalysis Ltd to further develop its environmentally friendly way to produce tantalum and titanium alloys. The company employs over 40 people and the new funds will mainly be used to support the scale-up of a novel semi-continuous pilot plant.

Cambridge Enterprise CEO Teri Willey said: "Funders are still supporting good innovation with the potential for a return on their investment as well as the development of a sustainable company employing highly qualified staff.

"Our newly launched Discovery Fund is established to keep this funding momentum for the earliest pre seed investment to support the next generation of companies emerging out of the University".

The University of Cambridge bio tech companies are continuing to attract funding from venture capitalists, business angels, and leading research and charitable foundations, in addition to accessing significant funding through partnering deals with major pharmaceutical companies, Cambridge Enterprise, the University's commercialisation arm, said.

As well as receiving upfront funding of $37m as part of its most recent partnering deal with Janssen Pharmaceutical, earlier this year, Astex Therapeutics received an award of up to £2m from the Wellcome Trust.

 



Previous articles
Cronto targets early pilot trials for its secure verification platform for e-business
For the Record: Acambis lays out strategy for fighting all legal actions filed by Bavarian Nordic with regard to smallpox vaccine MVA.
MMI Group's focus on drug development causes losses to widen
Celsis sees record ’07 growth after bedding down IVT acquisition
Cambridge Consultants moves CEO to US; to expand Cambridge Science Park operation
Reinvestment sees nCipher slip into 1H08 loss ahead of takeover by Thales
Abcam shares gain on news of ‘strong’ trading and as weak £ boosts bottom line
Light Blue Optics raises $26m to speed development of miniature laser projector
Briefs: Autonomy’s Interwoven fastest growing ECM firm; MMI to cut cost base; Bill, Melinda Gates awarded honorary Cambridge degrees
Snippets: Archer hands stem cells over to Hauser; Autonomy top corporate search firm
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Ophthalmos


Megan Howarth
Financial Director


Ophthalmos Limited's vision is to promote the use of ophthalmoscopy and "eye health" in general medical practice and to provide healthcare workers with revolutionary products to support this change. Its revolutionary lens-free ophthalmoscope – the Optyse - recently won the Edward de Bono Medal for

[Ophthalmos's profile]


Top20 Index




Currently: 131.89

Mortgage Comparison
Click here for advice or for mortgage comparison.

Marcus Evans conferences
Many businesses believe Marcus Evans presents the most interesting and enjoyable business courses!

Scam Events for Marcus Evans
Register for one of the next anti-scam events for Marcus Evans and learn about ethical corporate culture.

IFL
IFL are leaders in the Chrome industry. To find out more visit www.ifml.com